Risk factors for invasive fungal infection in patients undergoing orthotopic liver transplantation were examined. Thirty-four of 168 transplants were complicated within 100 days after transplantation by documented invasive fungal infection (Candida species, 28 patients; mycelial fungi, 5; both Candida and Aspergillus species, 1). In the multivariate Cox proportional hazards model, three baseline and two posttransplant variables were independently significant risk factors for infection: level of creatinine (hazard ratio = 1.4), length of transplant operation (HR = 1.2), retransplantation (HR = 3.2), abdominal or intrathoracic reoperations (HR = 2.5), and cytomegalovirus infection (HR = 8.5). Four predictors (creatinine of ^.0 mg/dL, operative time of ^ 11 h, retransplantation, and early colonization) assessable at the time of transplantation or shortly thereafter were incorporated into a simple predictive model for risk stratification. The risk of invasive fungal infection ranged from P/o in patients with no predictors to 6707o in patients with two or more predictors. Strategies to prevent invasive fungal infections after liver transplantation should be targeted to these high-risk groups.
tions of invasive disease, was done to evaluate fungal infections in liver transplant recipients. The goal was to identify risk factors that might prove useful in the development of more effective preventative and interventional strategies. This analysis focused on infections occurring within 100 days after transplantation, because fungal infections that occurred > 100 days after transplantation differed with respect to clinical characteristics and causative organisms. Cox proportional hazards regression, a method for analyzing events that occur over time, was used to assess relative risks.
Materials and Methods
Study population. Patients undergoing OLT at NEDH between July 1983 and July 1990 were studied. Nine patients surviving ^8 h were excluded from analysis. One chart was unavailable. All 187 remaining liver transplantations done in 158 patients were evaluated. The medical records for the 100 days after each liver transplant were reviewed. Donor management and organ retrieval were generally standardized during the period of this review. Between 1983 and April 1988, organs were preserved using Euro collins solution. From April 1988 until the end of the review period, University of Wisconsin preservation solution was used exclusively.
Transplantation was done as previously described [10] . Rejection episodes were initially treated with corticosteroid boluses (100-1000 mg). Recycled high-dose oral corticosteroids were used in cases in which an initial corticosteroid response was followed by sluggish improvement. Refractory rejection was treated with 10-14 days of OKT3.
Definitions. Stringent criteria for invasive fungal infection were established so that only unambiguous cases were included in the primary analysis. The following categories were defined: . The date of an invasive fungal infection was defined as the first positive histopathologic specimen or definitive culture; patients without invasive fungal infection were censored at death or 100 days after transplantation. Patients undergoing early retransplantation were analyzed as 1 case, using the initial transplant to assess baseline variables. For patients undergoing late retransplantation, each transplant was analyzed separately. None of the patients who were retransplanted had an invasive fungal infection before the second transplant. The results of the risk factor analyses were not appreciably altered when initial transplantations of late-retransplanted patients were excluded from the data set. Pretransplant and intraoperative factors were analyzed as baseline covariates. Posttransplant factors were incorporated as time-dependent covariates, which means that they were added to the model according to the time (in days since transplantation) at which they occurred and only if they occurred before invasive fungal infection or censoring. By using appropriate multiplicative terms, two-way interactions were examined. The validity of the proportional hazards assumption (i.e., that the HR did not vary significantly over time) was tested for each variable by including a time-dependent multiplicative term, log(7) X X, in which T is the time in days since transplantation and X is the independent variable [11] . Statistical significance was defined by P < .05 (Wald statistic or likelihood ratio, x2)-Risk factors were also examined by the method of risk set sampling [11] , in which each subject with invasive fungal infection (case) was randomly matched to a set of subjects without invasive fungal infection at the time (in days since transplant) that the case was detected to have invasive fungal infection. Conditional logistic regression (Stata 3, Santa Monica, CA) was then used to calculate adjusted odds ratios. In a sequential Cox regression analysis that was done to examine further the effect of fungal colonization, the median interval to invasive fungal infection was used as the cutoff to categorize infections as early or late. Finally, for purposes of risk stratification, a simple risk score model was developed using variables that were assessable either at the time of or within 1 week after transplant.
Independently significant predictors were selected by multivariate analysis, and patients were assigned to risk strata on the basis of the number of predictors present. The predictive value of the model was evaluated by measuring the area under the corresponding receiver operating characteristic (ROC) curve (Stata 3).
Results
We studied 158 patients who underwent OLT between ; table  2) . Colonization was a highly significant predictor for early infections but not for late infections. Furthermore, the highest risk of invasive fungal infection was associated with colonization detected by posttransplant day 3 (figure 2). In the 28 patients colonized before invasive fungal infection, the median interval between detection of colonization and invasive fungal infection was 7 days (range, 1-62). In each case, colonizing organisms from one or more sites belonged to the same species as the organism causing infection, including in 2 patients with Aspergillus organisms in sputum culture 3 and 8 days before the diagnosis of disseminated aspergillosis.
The risk of infection did not rise with increasing number of sites of colonization, nor did it vary significantly according to the site of colonization (table 2) Another recent study examined risk factors for invasive aspergillosis using patients colonized with Aspergillus species as the comparison group. Elevated creatinine and use of OKT3 were the only independently significant risk factors in multivariate logistic analysis [22] . The goals of the present study were to assess independently significant risk factors for strictly defined invasive fungal infections after OLT to aid in the development of more effective strategies for prevention. Risk factors were analyzed by using the Cox proportional hazards regression, an appropriate method for analyzing data from cohort studies, in which outcomes and exposures occur over time. Posttransplant exposures, such as CM V infection and immunosuppressive therapy for rejection, were examined as time-dependent covariates, so that they were included in the model according to the time at which they occurred and only if they occurred before invasive fungal infection.
There were 34 invasive fungal infections within 100 days of OLT, most (85^) of which were caused by Candida species. A major epidemiologic distinction between mycelial and candidal infections was that the former tended to occur later in the posttransplant period. The mycelial infections were still predominantly nosocomial in origin, as 5 of 6 infections occurred during the initial hospitalization associated with transplantation. Temporospatial clustering of candidal and mycelial infections was not evident, and routine infection control surveillance during this period did not detect sources of nosocomial transmission. However, because of the retrospective nature of this study, additional epidemiologic data, such as the intensity of environmental exposure to Aspergillus spores, were not available. Another utility of risk factor analysis is to aid in the development of predictive models for risk stratification. A simple predictive model was generated using variables that were assessable at the time of transplantation or shortly thereafter.
Severe renal insufficiency (creatinine of ^.0 mg/dL, primarily due to hepatorenal syndrome), prolonged operative time (^11 h), retransplantation, and colonization within 3 days of OLT were highly significant, independent predictors. Patients were stratified into low-, moderate-, and high-risk groups on the basis of whether no, one, or two or more predictors were present. The incidence of invasive fungal infection ranged from \7c (1/72) in the low-risk group to 67% (20/30) in the high-risk group. If patients were colonized within 3 days of transplantation and had one or more of the other baseline predictors, the risk of invasive fungal infection by posttransplant day 10 was 63^ (12/19). Therefore, in these high-risk patients, the threshold for diagnostic evaluation and empiric therapy for presumptive invasive fungal infection should be low.
Ultimately, effective methods to prevent invasive fungal infection in liver transplant recipients are needed. If prospectively validated, the predictive model described here may be useful for selecting patients who will benefit from antifungal prophylaxis. The strategy of selective antifungal prophylaxis was applied to a consecutive series of liver transplant recipients at Baylor University Medical Center, where low-dose intravenous amphotericin B was given to patients in the ICU, those receiving lactulose therapy for encephalopathy, or those with positive fungal cultures before transplantation [28] . The overall incidence of serious fungal infection was 7.5*, and only 2 of 13 fungal infections were fatal. However, the number of patients receiving antifungal prophylaxis and methods of diagnosis were not described. The efficacy of different strategies for prevention of invasive fungal infection after liver transplantation will be better defined by prospective comparative trials.
In summary, this study confirms the significant morbidity and mortality associated with invasive fungal infections, primarily due to Candida species, in liver transplant recipients. A limited number of risk factors were independently significant and were useful for stratification of patients by risk of infection. Interventional strategies to modify risk factors or initiate antifungal prophylaxis in high-risk patients may reduce the incidence of invasive fungal infection and warrant further study.
